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Abstract
Epilepsy is chronic neurological disease characterized by occurrence of spontaneous recurrent seizures affecting 
approximately 1% of people. One of the most common causes of epilepsy in adults is a stroke. The precise mechanism 
of development of vascular epilepsy is not known, and thus no reliable biomarker of postischemic epileptogenesis 
currently exists. Blood-brain barrier (BBB) impairment is phenomenon observed in several pathologies including 
stroke after which epilepsy often develops. Blood components such as albumin or thrombin have been experimentally 
shown to possess the capacity to increase excitability which results in seizures and epileptogenesis. We hypothesize that 
severity of the BBB breakdown during first weeks after the stroke can be used as a biomarker of postischemic
epileptogenesis. This paper describes free MATLAB based software /Gd-Tracker/ and methodology developed for 
assessment of BBB permeability from magnetic resonance (MR) scans based on statistical voxel to voxel comparison of 
sequences with and without Gd-DTPA contrast. This software allows to evaluate extent and magnitude of impaired BBB 
region and thus serve as a tool for visualization and quantification of BBB breakdown.
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Introduction 
Epilepsy is a chronic disorder of the brain that affects 
people of all ages. According to WHO approximately 
50 million people worldwide suffer from epilepsy, 
which makes it one of the most common neurological 
disease globally [1].
The most common cause of epilepsy in adults older 
than 35 years (more than 50% of all new cases) is 
cerebral ischemia (stroke). The risk of developing 
epilepsy in patients after the stroke rises up to 9%. 
Patients who develop vascular epilepsy after the stroke 
have a significantly higher disability and are less likely 
to be independent in activities of daily living [2]. 
Search for new treatments to preventing development
of epilepsy represents the main direction of contem-
porary epilepsy research.
Although the precise mechanism of postischemic 
epileptogenesis is not known, several proposed casca-
des are currently in the focus of the neuroscience teams 
world-wide. It seems reasonable to therapeutically 
intervene only in those patients where epileptogenesis 
occurs. Currently, we lack a reliable marker to identify 
patients at increased risk of developing postischemic 
epilepsy.
Blood-brain barrier (BBB) dysfunction is one of the 
candidate mechanisms which plays an important role in
the development of epilepsy after stroke. The BBB is 
an anatomical structure separating vascular and neural 
brain compartments. Its proper function is essential for 
normal brain activity by maintaining the homeostasis
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of the brain microenvironment [3]. Loss of BBB 
integrity leads to extravasation of plasma proteins into 
the neuronal tissue and vasogenic brain edema [4]. 
Defective BBB can persist for long periods after the 
stroke and may cause secondary inflammation and 
neuronal dysfunction [5–6]. Several plasma proteins 
including albumin and thrombin [7–8] as well as 
inflammatory cytokines have been shown to trigger 
both acute epileptiform activity (acute symptomatic 
seizures) and epileptogenesis [9–10]. Conversely, 
experimentally induced epileptic seizures in animal 
models transiently compromise BBB [11–12].
We hypothesize that severity of BBB dysfunction 
and extent and time profile of inflammation induced by 
stroke correlate with epileptogenesis. To address this 
hypothesis a reliable method for detection and 
quantification of BBB is needed. Routine diagnostic 
protocol usually includes MRI with different sequences 
allowing sensitive identification of ischemic area only. 
Therefore, gadolinium (Gd) based contrast MR im-
aging must be implemented to provide information
about the BBB properties. Because of its paramagnetic 
pro-perties, intravenously administered chelated 
organic gadolinium complexes enhance nuclear 
relaxation rates and increase contrast. Standard 
perfusion imaging protocol is based on dynamic 
acquisition during fast bolus perfusion of chelated Gd 
solution. However, it is demanding method which 
prevent its use as a routine diagnostic protocol. In this 
paper, we present a soft-ware /Gd-Tracker/ based on 
statistical methods [13] which allows semi-automatic 
BBB permeability quan-tification from two sets of T1-
weighted MR images acquired before and after Gd-
DTPA application. The software is freely accessible on 
http://bbb.biomed.cas.cz.
Methods and materials 
In total 30 patients (17 men, age 65 ±11 years and 13 
women, age 69 ± 10 years) were included in this study 
to verify sensitivity and selectivity of algorithms. The 
study was approved by the institutional ethical 
committee of Motol University Hospital and all 
subjects provided their informed consent. Only patients 
with acute stroke in supratentorial region were 
selected. Patients with previous cortical ischemic 
lesions, allergy to contrast agent and established
epilepsy were excluded.
A modified clinical MRI protocol with Gadovist 
(Gd-DTPA, Bayer Pharma AG, Germany) contrast 
agent was performed 7–12 days after the stroke. 
A solution of contrast agent (10 ml) was injected 
approximately 3 minutes before the acquisition of 
contrast sequences start. MRI was performed using
1.5T Phillips Ingenia scanner.
Algorithms used in this study are adopted from [13]
and the entire procedure is summarized and graphically 
presented in Fig. 1. The method is based on 
comparison of two consecutively recorded T1-
weighted MR images of head: native MRI and MRI 
with contrast agent Gd-DTPA (Gadovist). Gadovist 
does not cross BBB in healthy tissue while in regions 
with compromised barrier it leaks to the brain tissue
and increases signal intensity. Thus regions with 
significantly higher signal after Gadovist injection are 
considered to have BBB impairment.
Acquired data were processed in our software /Gd-
Tracker/ written in Matlab environment (version 
R2014b, The Mathworks, Nattick, USA). The software
processes datasets in several steps: construction of 
Fig. 1: Method summarization. (1) Pre and post contrast images are registered. (2) T-test of corresponding regions is 
performed (3) resulting in binary significance map where areas with significant changes are highlighted. (4) Difference 
of intensities in these areas is calculated and eye-sinus normalized.
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binary map of voxels with significant difference
(after Gd contrast), quantification of this difference, 
normalization of the data by eye(0)/blood(1) scale and 
visualization in brain tissue containing voxels which 
were identified by segmentation.
Localization of significant changes
First for each pixel (all algorithms are 2D - each slice 
of 3D volume is computed individually, thus we use 
term pixel instead of voxel) of pre- and post- contrast 
images surrounding 3×3 area is selected for compar-
ison. The reason why 3×3 neighborhood is used instead 
of comparing single pixels is an effort to suppress 
possible inaccurate registration. During the image 
registration, one image is spatially transformed to 
exactly match other image. Some pixels do not have 
perfect alignment and false positive difference between 
such pixels can be observed. This effect is decreased 
by using a matrix of surrounding pixels and its sta-
tistical comparison.
Each pair of the two corresponding neighborhoods 
(from pre and post contrast images) is compared using
unpaired t-test to determine changes between pre and 
post contrast images. Pixels (represented by its 
neighborhood) with P-values smaller than 0.05 are 
considered to be statistically significant and are used 
for the creation of binary map, where significant pixels 
are represented by 1 and nonsignificant by 0. FDR 
(false discovery rate) statistical correction is used to 
suppress correct the impact of multiple comparisons.
Calculation of difference in intensity
The difference between pre and post contrast images 
in pixels defined by significance map is calculated 
by equation 1 in following step. The difference 
corresponds to amount of contrast agent in the tissue.
(1)
Data normalization 
To enable comparison between subjects and sessions 
calculated values of difference are normalized by two 
reference values [13]. Value in eye ball is considered 
as minimal (0), because Gd contrast does not leak to
a vitreous body of healthy eye ball. On the other hand, 
intensity in dural venous sinuses (sinus sagittalis
superior, transversus or rectus) is considered as maxi-
mal (1), because the highest concentration of contrast 
agent is in blood.
Larger area (9×9 pixels) is repeatedly selected (two 
or three different places from one tissue) instead of 
representing tissue intensity by one value from a single
pixel.
Fig. 2: Screen shot of the /Gd-Tracker/ software user interface. Partial-results of all steps of the described algorithm 
are shown in subplots: pre-contrast, post-contrast image, binary map of the significant changes and the normalized 
intensity difference respectively in upper row, brain maps with grey/white matter and CSF, all maps merged to final 
brain mask and the native image merged with the intensity difference in lower row. Buttons for program control on the 
left side of the window and buttons for listing though slices (mediolateral plane) are located below these subplots 
together with the button for saving results of analysis to NIfTI.
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Significant outliers due to various artifacts or other 
disturbances coming from method of data acquisition 
were often present in these sets. These outliers are 
excluded to obtain homogenous data sets. Gaussian fit 
is consequently applied on outliers-free data and 
quartiles of resulting distributions are considered as 
exact values for normalization.
The result of the normalization is a dataset of values 
between 0 and 1 corresponding to individual minimal 
(tissue with no Gd) and maximal value (blood con-
taining a maximal amount of Gd). This transformation 
allows direct comparison between two different ses-
sions and between individuals.
Image segmentation 
To separate brain tissue from other tissues, a set of 
image segmentation techniques provided by SPM12
toolbox for Matlab (Wellcome Trust Centre for Neuro-
imaging, UCL, UK) were used. New Segmentation tool 
(function of SPM12 toolbox) performs an image 
registration, tissue classification (based on a mixture of 
Gaussians and nonlinear registration with tissue 
probability maps) and bias correction. The process 
successfully identifies grey matter, white matter, 
cerebrospinal fluid (CSF), bone, air, and background. 
Final segmentation mask, which is used in our 
algorithm is obtained as the unification of grey, white 
matter and CSF – i.e. brain tissue [14].
Results 
The result of this study is a semi-automatic software 
which enables to quantitatively assess permeability of 
the BBB in MRI scans acquired without and with 
gadolinium contrast. User interface of the software is 
introduced in Fig. 2 where each steps of the entire 
procedure are shown.
The implemented pre-post comparison (with-without 
contrast) detects areas with significantly different 
intensities which correspond to regions with impaired 
BBB. Detected regions precisely overlap contrast-
enhanced areas in T1 images as shown in Fig. 3. 
Images were further eye-sinus normalized, thus the 
change of BBB impairment for individual patient and 
session can be quantified. 
Regions with impaired BBB were successfully de-
tected in all 30 studied patients by /Gd-Tracker/ 
software and confirmed by conventional visual ana-
lysis. The quantification was successful either in cases 
of strong and obvious impairment but also in cases 
where the leakage was barely visible by human eye.
Datasets obtained by our processing can be further 
used for either visualization or analysis in other soft-
ware. For example, 3DSlicer, an open source software 
package [15] can be used to calculate leakage size from 
permeability change map or to construct 3D model 
(Fig. 4.).
Fig. 3: Comparison of Gd contrast MRI images (left) 
and images enhanced by described method (right). 
Stroke lesion visible on contrast images (marked by an 
arrow) was precisely identified and highlighted by our 
software.
Fig. 4: 3D model of the brain tissue. Brain vessels are 
blue, region with impaired BBB detected by our 
software is depicted in red color. Surface and volume 
of lesion can be calculated for comparison with other 
prospective measurements.
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Discussion 
We have shown that software /Gd-Tracker/ presented 
in this paper is a useful tool for quantification of 
changes in BBB permeability in vicinity of ischemic
lesion. To detect and quantify discrete changes in the 
tissue intensity after the Gd contrast injection, high
sensitivity of the algorithm is set. Automatic lesion 
detection would require to adopt a different approach
because high algorithm sensitivity frequently leads to 
detection of larger area then ischemic region due to 
leak of contrast in periischemic tissue and to false 
positive results located mostly around vessels and other 
well-perfused tissues. These false positive pixels can 
be avoided by precise segmentation of the brain while 
it is mostly located outside of the brain tissue 
(retrobulbar structures). High sensitivity settings were 
chosen to avoid false negative results of pixels with 
mild increase in signal intensity due to enhanced BBB 
permeability which happens especially on lesion 
surroundings where intensity differences are usually 
low. The problem with hypersensitivity is minor in our 
study design because exact location of lesion is known 
from other MRI series as assessed by conventional 
visual analysis prior to BBB permeability detection.
We have elaborated eye-sinus normalization to 
enable interindividual and intersession comparison. 
While vitreous body of the eye ball represents stable 
level and can be efficiently used for setting the lower 
limit range, setting of the maximal value used for upper 
limit seems to be more challenging. We used intensity 
as measured in the region of interest corresponding to 
dural venous sinuses which yielded stable results. The 
normalization to the level of the muscle tissue is other 
commonly used method. However, with this approach 
we have observed high variability in the intensity and 
in some cases the muscle intensity was lower than that 
observed in the ischemic area (data not shown). 
Altogether the eye-sinus normalization approach seems 
to be more appropriate for the purpose of this study.
Current version of the /Gd-Tracker/ software was 
tested on datasets and is reliable tool to visualize and 
quantify poststroke BBB impairment.
Conclusion 
The result of this study is MATLAB based software 
/Gd-Tracker/ allowing quantitative assessment of 
blood-brain barrier (BBB) permeability from MRI with 
and without gadolinium contrast agent. This software 
is able to detect significant intensity changes cor-
responding to pathological areas of the brain and 
following normalisation to estimate size and severity of 
the BBB impairment. /Gd-Tracker/ can by freely 
downloaded at http://bbb.biomed.cas.cz/.
Acknowledgement 
The study was supported by grant project no. 15-
33115A from the Czech Health Research Council, by 
project OPPK BrainView CZ.2.16/3.1.00/21544, by the 
Czech-BioImaging large RI project (LM2015062 
funded by MEYS CR) and SGS15/198/OHK3/3T/13.
References 
[1] http://www.who.int/mediacentre/factsheets/fs999/en [cit. 24. 1.
2017].
[2] Camilo, O., Goldstein, L.B.: Seizures and epilepsy after ische-
mic stroke. Stroke; a journal of cerebral circulation, 2004, 
vol. 35, no. 7, p. 1769–1775.
[3] Iadecola, C., Nedergaard, M.: Glial regulation of the cerebral 
microvasculature. Nature neuroscience, 2007, vol. 10, no. 11, 
p. 1369–1376.
[4] Stanimirovic, D.B., Friedman, A.: Pathophysiology of the 
neurovascular unit: disease cause or consequence? Journal of 
cerebral blood flow and metabolism, 2012, vol. 32, no. 7, 
p. 1207–1221.
[5] Abbott, N.J., Friedman, A.: Overview and introduction: the 
blood-brain barrier in health and disease. Epilepsia, 2012, 
vol. 53, no. 6, p. 1–6.
[6] Vezzani, A., Friedman, A., Dingledine, R.J.: The role of inflam-
mation in epileptogenesis. Neuropharmacology, 2013, no. 69, 
p. 16–24.
[7] Friedman, A.: Blood-brain barrier dysfunction, status epilep-
ticus, seizures, and epilepsy: a puzzle of a chicken and egg?
Epilepsia, 2011, vol. 52, no. 8, p. 19–20.
[8] Maggio, N., et al.: Treating seizures and epilepsy with anticoa-
gulants? Frontiers in cellular neuroscience, 2013, vol. 7, no. 19.
[9] Ivens, S., et al.: TGF-beta receptor-mediated albumin uptake 
into astrocytes is involved in neocortical epileptogenesis. Brain, 
2007, no. 130, p. 535–547.
[10] Marchi, N., et al.: Seizure-promoting effect of blood-brain 
barrier disruption. Epilepsia, 2007, vol. 48, no. 4, p. 732–742.
[11] Zimmermann, A., Domoki, F., Bari, F.: Seizure-induced alter-
ations in cerebrovascular function in the neonate. Developmen-
tal neuroscience, 2008, vol. 30, no. 5, p. 293–305.
[12] Danjo, S., Ishihara, Y., Watanabe, M., Nakamura, Y., Itoh, K.:
Pentylentetrazole-induced loss of blood-brain barrier integrity 
involves excess nitric oxide generation by neuronal nitric oxide 
synthase. Brain research, 2013, vol. 1530, p. 44–53.
[13] Chassidim, Y., et al.: Quantitative imaging assessment of blood-
brain barrier permeability in humans. Fluids and barriers of the 
CNS, 2013, vol. 10, no. 1, p. 9.
[14] Ashburner, J., Friston, K.J.: Unified segmentation. Neuroimage, 
2005, vol. 26, no. 3, p. 839–51.
ORIGINAL RESEARCH
48 
 
Lekar a technika – Clinician and Technology 2017, vol. 47(2), pp. 43–48 
ISSN 0301-5491 (Print), ISSN 2336-5552 (Online) 
[15] Fedorov, A., Beichel, R., Kalpathy-Cramer, J., Finet, J., Fillion-
Robin, J-C., Pujol, S., Bauer, C., Jennings, D., Fennessy, F.M., 
Sonka, M., Buatti, J., Aylward, S.R., Miller, J.V., Pieper, S., 
Kikinis, R.: 3D Slicer as an Image Computing Platform for the 
Quantitative Imaging Network. Magn Reson Imaging, 2012, 
vol. 30, no. 9, p. 1323–41.
Assoc.Prof. Jakub Otáhal, Ph.D.
or
Ing. David Kala
Institute of Physiology
Czech Academy of Sciences
?????????????????????????????
E-mail: jakub.otahal@fgu.cas.cz
david.kala@fgu.cas.cz
